Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Treatment of endometrial cancer].
Descamps P, Calais G, Chapet S, Gillard P, Body G, Lansac J. Descamps P, et al. Among authors: calais g. Rev Prat. 1994 Apr 15;44(8):1080-4. Rev Prat. 1994. PMID: 7939326 Review. French. No abstract available.
[Indications for castration in women treated for breast cancer].
Chapet S, Bougnoux AR, Berger C, Descamps P, Body G, Calais G, Bougnoux P, Le Floch O, Lansac J. Chapet S, et al. Among authors: calais g. J Gynecol Obstet Biol Reprod (Paris). 1996;25(5):445-50. J Gynecol Obstet Biol Reprod (Paris). 1996. PMID: 8926344 Review. French.
Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.
Berger C, de Muret A, Garaud P, Chapet S, Bourlier P, Reynaud-Bougnoux A, Dorval E, de Calan L, Huten N, le Folch O, Calais G. Berger C, et al. Among authors: calais g. Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):619-27. doi: 10.1016/s0360-3016(96)00577-9. Int J Radiat Oncol Biol Phys. 1997. PMID: 9112461
Relationship between 5-fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy.
Beneton M, Chapet S, Blasco H, Giraudeau B, Boisdron-Celle M, Deporte-Fety R, Denis F, Narcisso B, Calais G, Le Guellec C. Beneton M, et al. Among authors: calais g. Br J Clin Pharmacol. 2007 Nov;64(5):613-21. doi: 10.1111/j.1365-2125.2007.02951.x. Epub 2007 Jun 19. Br J Clin Pharmacol. 2007. PMID: 17578483 Free PMC article.
Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.
Fesneau M, Pointreau Y, Chapet S, Martin L, Pommier P, Alfonsi M, Laguerre B, Feham N, Berger C, Garaud P, Calais G. Fesneau M, et al. Among authors: calais g. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):154-63. doi: 10.1016/j.ijrobp.2009.01.033. Int J Radiat Oncol Biol Phys. 2010. PMID: 19386430 Clinical Trial.
Curative intent Stereotactic Ablative Radiation Therapy (SABR) for treatment of lung oligometastases from head and neck squamous cell carcinoma (HNSCC): a multi-institutional retrospective study.
Debbi K, Loganadane G, To NH, Kinj R, Husain ZA, Chapet S, Nguyen NP, Barillot I, Benezery K, Belkacemi Y, Calais G. Debbi K, et al. Among authors: calais g. Br J Radiol. 2022 May 1;95(1133):20210033. doi: 10.1259/bjr.20210033. Epub 2022 Feb 22. Br J Radiol. 2022. PMID: 35143326 Free PMC article.
Simultaneous or staged resection for synchronous liver metastasis and primary rectal cancer: a propensity score matching analysis.
Karam E, Bucur P, Gil C, Sindayigaya R, Tabchouri N, Barbier L, Pabst-Giger U, Bourlier P, Lecomte T, Moussata D, Chapet S, Calais G, Ouaissi M, Salamé E. Karam E, et al. Among authors: calais g. BMC Gastroenterol. 2022 Apr 21;22(1):201. doi: 10.1186/s12876-022-02250-9. BMC Gastroenterol. 2022. PMID: 35448953 Free PMC article.
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group.
Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, Bardet E, Pierart M, Briffaux A; EORTC Radiotherapy Group. Bosset JF, et al. Among authors: calais g. Eur J Cancer. 2004 Jan;40(2):219-24. doi: 10.1016/j.ejca.2003.09.032. Eur J Cancer. 2004. PMID: 14728936 Clinical Trial.
Chemotherapy with preoperative radiotherapy in rectal cancer.
Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC; EORTC Radiotherapy Group Trial 22921. Bosset JF, et al. Among authors: calais g. N Engl J Med. 2006 Sep 14;355(11):1114-23. doi: 10.1056/NEJMoa060829. N Engl J Med. 2006. PMID: 16971718 Free article. Clinical Trial.
Rectal cancer.
Legoux JL, Lehur PA, Penna C, Calais G, Roseau G, Calan LD. Legoux JL, et al. Among authors: calais g. Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S43-2S51. Gastroenterol Clin Biol. 2006. PMID: 17151562 Free article. Review. No abstract available.
Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921.
den Dulk M, Collette L, van de Velde CJ, Marijnen CA, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bosset JF; EORTC Radiation Oncology Group. den Dulk M, et al. Among authors: calais g. Eur J Cancer. 2007 Aug;43(12):1821-8. doi: 10.1016/j.ejca.2007.05.025. Epub 2007 Jul 12. Eur J Cancer. 2007. PMID: 17627809 Clinical Trial.
[Documentation management: from theory to practice].
Barillot I, Chapet S, Farcy Jacquet MP, Reynaud-Bougnoux A, Aget H, Bramoullé C, Louisot P, Calais G. Barillot I, et al. Among authors: calais g. Cancer Radiother. 2008 Nov;12(6-7):606-9. doi: 10.1016/j.canrad.2008.07.003. Epub 2008 Aug 5. Cancer Radiother. 2008. PMID: 18684655 French.
Induction chemotherapy in head and neck cancer: a new paradigm.
Pointreau Y, Atean I, Fayette J, Calais G, Lefebvre JL. Pointreau Y, et al. Among authors: calais g. Anticancer Drugs. 2011 Aug;22(7):613-20. doi: 10.1097/CAD.0b013e3283425871. Anticancer Drugs. 2011. PMID: 21160420 Review.
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF, Calais G, Mineur L, Maingon P, Stojanovic-Rundic S, Bensadoun RJ, Bardet E, Beny A, Ollier JC, Bolla M, Marchal D, Van Laethem JL, Klein V, Giralt J, Clavère P, Glanzmann C, Cellier P, Collette L; EORTC Radiation Oncology Group. Bosset JF, et al. Among authors: calais g. Lancet Oncol. 2014 Feb;15(2):184-90. doi: 10.1016/S1470-2045(13)70599-0. Epub 2014 Jan 17. Lancet Oncol. 2014. PMID: 24440473 Clinical Trial.
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial.
Guigay J, Aupérin A, Fayette J, Saada-Bouzid E, Lafond C, Taberna M, Geoffrois L, Martin L, Capitain O, Cupissol D, Castanie H, Vansteene D, Schafhausen P, Johnson A, Even C, Sire C, Duplomb S, Evrard C, Delord JP, Laguerre B, Zanetta S, Chevassus-Clément C, Fraslin A, Louat F, Sinigaglia L, Keilholz U, Bourhis J, Mesia R; GORTEC; AIO; TTCC, and UniCancer Head and Neck groups. Guigay J, et al. Lancet Oncol. 2021 Apr;22(4):463-475. doi: 10.1016/S1470-2045(20)30755-5. Epub 2021 Mar 5. Lancet Oncol. 2021. PMID: 33684370 Clinical Trial.
Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate Cancer.
Pobel C, Laurent E, Florence AM, Fromont G, Calais G, Narciso B, Linassier C, Cancel M. Pobel C, et al. Among authors: calais g. Clin Genitourin Cancer. 2022 Oct;20(5):495.e1-495.e9. doi: 10.1016/j.clgc.2022.04.004. Epub 2022 Apr 21. Clin Genitourin Cancer. 2022. PMID: 35562276
Early secondary acute myelogenous leukemia in breast cancer patients after treatment with mitoxantrone, cyclophosphamide, fluorouracil and radiation therapy.
Linassier C, Barin C, Calais G, Letortorec S, Brémond JL, Delain M, Petit A, Georget MT, Cartron G, Raban N, Benboubker L, Leloup R, Binet C, Lamagnère JP, Colombat P. Linassier C, et al. Among authors: calais g. Ann Oncol. 2000 Oct;11(10):1289-94. doi: 10.1023/a:1008375016038. Ann Oncol. 2000. PMID: 11106118 Free article.
Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems.
Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Oudinot P, Calais G. Denis F, et al. Among authors: calais g. Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):93-8. doi: 10.1016/s0360-3016(02)03819-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 12504040 Clinical Trial.
Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.
Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Bergerot P, Rhein B, Tortochaux J, Calais G. Denis F, et al. Among authors: calais g. J Clin Oncol. 2004 Jan 1;22(1):69-76. doi: 10.1200/JCO.2004.08.021. Epub 2003 Dec 2. J Clin Oncol. 2004. PMID: 14657228 Clinical Trial.
Concurrent administration of adjuvant chemotherapy and radiotherapy after breast-conserving surgery enhances late toxicities: long-term results of the ARCOSEIN multicenter randomized study.
Toledano A, Garaud P, Serin D, Fourquet A, Bosset JF, Breteau N, Body G, Azria D, Le Floch O, Calais G. Toledano A, et al. Among authors: calais g. Int J Radiat Oncol Biol Phys. 2006 Jun 1;65(2):324-32. doi: 10.1016/j.ijrobp.2005.12.020. Epub 2006 Mar 20. Int J Radiat Oncol Biol Phys. 2006. PMID: 16542788 Clinical Trial.
Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
Racadot S, Mercier M, Dussart S, Dessard-Diana B, Bensadoun RJ, Martin M, Malaurie E, Favrel V, Housset M, Durdux C, Journel C, Calais G, Huet J, Pillet G, Hennequin C, Haddad E, Diana C, Blaska-Jaulerry B, Henry-Amar M, Géhanno P, Baillet F, Mazeron JJ. Racadot S, et al. Among authors: calais g. Radiother Oncol. 2008 May;87(2):164-72. doi: 10.1016/j.radonc.2007.12.021. Epub 2008 Jan 25. Radiother Oncol. 2008. PMID: 18222010 Clinical Trial.
Phase II study of preoperative radiation plus concurrent daily tegafur-uracil (UFT) with leucovorin for locally advanced rectal cancer.
Cellier P, Leduc B, Martin L, Vié B, Chevelle C, Vendrely V, Salemkour A, Carrie C, Calais G, Burtin P, Campion L, Boisdron-Celle M, Morel A, Berger V, Gamelin E. Cellier P, et al. Among authors: calais g. BMC Cancer. 2011 Mar 16;11:98. doi: 10.1186/1471-2407-11-98. BMC Cancer. 2011. PMID: 21410976 Free PMC article. Clinical Trial.
Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
Bourhis J, Sire C, Graff P, Grégoire V, Maingon P, Calais G, Gery B, Martin L, Alfonsi M, Desprez P, Pignon T, Bardet E, Rives M, Geoffrois L, Daly-Schveitzer N, Sen S, Tuchais C, Dupuis O, Guerif S, Lapeyre M, Favrel V, Hamoir M, Lusinchi A, Temam S, Pinna A, Tao YG, Blanchard P, Aupérin A. Bourhis J, et al. Among authors: calais g. Lancet Oncol. 2012 Feb;13(2):145-53. doi: 10.1016/S1470-2045(11)70346-1. Epub 2012 Jan 18. Lancet Oncol. 2012. PMID: 22261362 Clinical Trial.
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?
Bonnetain F, Bosset JF, Gerard JP, Calais G, Conroy T, Mineur L, Bouché O, Maingon P, Chapet O, Radosevic-Jelic L, Methy N, Collette L. Bonnetain F, et al. Among authors: calais g. Eur J Cancer. 2012 Aug;48(12):1781-90. doi: 10.1016/j.ejca.2012.03.016. Epub 2012 Apr 14. Eur J Cancer. 2012. PMID: 22507892
Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
Tao Y, Aupérin A, Graff P, Lapeyre M, Grégoire V, Maingon P, Geoffrois L, Verrelle P, Calais G, Gery B, Martin L, Alfonsi M, Deprez P, Bardet E, Pignon T, Rives M, Sire C, Bourhis J. Tao Y, et al. Among authors: calais g. Oral Oncol. 2017 Aug;71:61-66. doi: 10.1016/j.oraloncology.2017.06.002. Epub 2017 Jun 9. Oral Oncol. 2017. PMID: 28688693 Clinical Trial.
Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases.
Dahan LS, Giorgi R, Vergez S, Le Taillandier de Gabory L, Costes-Martineau V, Herman P, Poissonnet G, Mauvais O, Malard O, Garrel R, Uro-Coste E, Barry B, Bach C, Chevalier D, Mouawad F, Merol JC, Bastit V, Thariat J, Gilain L, Dufour X, Righini CA, Moya-Plana A, Even C, Radulesco T, Michel J, Baujat B, Fakhry N; REFCOR members. Dahan LS, et al. Eur J Surg Oncol. 2021 Jun;47(6):1376-1383. doi: 10.1016/j.ejso.2020.11.123. Epub 2020 Nov 21. Eur J Surg Oncol. 2021. PMID: 33248902
Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial.
Janoray G, Pointreau Y, Alfonsi M, Sire C, Geoffrois L, de Raucourt D, Bardet E, Calais MH, Garaud P, Calais G. Janoray G, et al. Among authors: calais g, calais mh. Eur J Cancer. 2020 Jul;133:86-93. doi: 10.1016/j.ejca.2020.04.009. Epub 2020 May 23. Eur J Cancer. 2020. PMID: 32454417 Clinical Trial.
204 results